Clade I mpox: affected countries
This page provides an overview of countries reporting clade I mpox cases (historic or current), indicating where there may be a risk of clade I mpox exposure.
Figure 1. African Region countries reporting laboratory confirmed clade I mpox (historic or current)
The situation may change rapidly in different countries. It is possible for mpox cases to be reported in countries who have not reported clade I mpox to date. Mpox of an unknown clade has been reported in Gabon but is presumed to be clade I (due to case travel history).
Given the continuing spread of clade I mpox, please check this webpage regularly for any updates to the countries included. This table is derived from the methodology outlined in the Mpox: scenarios and technical elements of preparedness and response for clade I technical briefing 9.
Table 1. Countries reporting clade I mpox where there may be a risk of clade I mpox exposure
| Country | Likelihood of exposure to clade I mpox |
|---|---|
| Democratic Republic of the Congo | Higher |
| Burundi | Higher |
| Uganda | Higher |
| Central African Republic | Lower |
| Kenya | Lower |
| Republic of the Congo | Lower |
| Rwanda | Lower |
| Gabon | Lower |
| Cameroon | Clade I mpox previously reported but not in 2024 |
| Sudan | Clade I mpox previously reported but not in 2024 |
| South Sudan | Clade I mpox previously reported but not in 2024 |
There are reports of single imported clade I mpox cases in the following countries. There is no evidence of transmission in country and thus the risk of exposure is considered minimal:
- India
- Sweden
- Thailand
These countries are not considered as clade I mpox affected for purposes of testing or guidance.